Trial Profile
A Phase 1, Randomized, Open-Label, Two-Period Crossover Study Evaluating the Relative Bioavailability and Safety of the AG-348 Tablet and Capsule Formulations After Single-Dose Administration in Healthy Adults
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 15 Jan 2018
Price :
$35
*
At a glance
- Drugs Mitapivat (Primary)
- Indications Haemolytic anaemia
- Focus Pharmacokinetics
- Sponsors Agios Pharmaceuticals
- 15 Jan 2018 New trial record